Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.

Lignende værker

• Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?
  af: Zapf, J, et al.
  Udgivet: (1992)
• Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing.
  af: Daughaday, W H, et al.
  Udgivet: (1993)
• Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II.
  af: Shapiro, E T, et al.
  Udgivet: (1990)
• Bioactive insulin-like growth factors as a possible molecular target for non-islet cell tumor hypoglycemia
  af: Setoyama, Takeshi, et al.
  Udgivet: (2014)
• Retroperitoneal Solitary Fibrous Tumor-Induced Hypoglycemia Associated with High Molecular Weight Insulin-Like Growth Factor II
  af: Yamakawa-Yokota, Fumiko, et al.
  Udgivet: (2010)